![](/img/cover-not-exists.png)
346PPhase II study of DHP107 oral paclitaxel in first-line, HER2 negative recurrent/metastatic breast cancer (OPTIMAL study, NCT03315364)
Ahn, J-H, Lee, K S, Lee, K-H, Seo, J H, KANG, S Y, Sohn, J, Yang, Y, Park, K H, Moon, Y W, Lim, S T, Yoon, K E, Cho, H J, Kim, S -BVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.041
Date:
October, 2019
File:
PDF, 81 KB
2019